The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age
- PMID: 3914926
- PMCID: PMC2536468
The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age
Abstract
PIP: Infants should receive live trivalent oral poliovirus vaccine (TOPV) and DPT immunization as early in life as possible in order to minimize the time that they are at risk of contracting these vaccine-preventable diseases. Passively acquired circulating maternal antibodies provide protection in the 1st few weeks or months of life. Although these antibodies may modify or block the serum immune response during the 1st few weeks of life, the 1st or priming dose of DPT can be given effectively after 4 weeks of age. TOPV administered to infants during the 1st week of life results in intestinal infections and local immune responses in 50-100% of infants and serum antibody responses in 30-70% of infants. The serum antibody response following TOPV administration at 4-8 weeks of age is as effective as vaccine administered to older infants. The WHO Program on Immunization recommends initiating DPT and TOPV schedules at 6 weeks of age. In countries where poliomyelitis has not been controlled, TOPV should be given at birth, or at 1st contact with the health services, then at 6 weeks of age, followed by 2 additional doses 4 weeks apart. (author's)
Similar articles
-
[Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. I. Immune response and reactions to simultaneous administration of DPT, TOPV and hepatitis B vaccine].Zhonghua Liu Xing Bing Xue Za Zhi. 1989 Aug;10(4):206-9. Zhonghua Liu Xing Bing Xue Za Zhi. 1989. PMID: 2805046 Chinese.
-
Comparison of immunogenicity of combined DPT--inactivated injectable polio vaccine (DPT - IPV) and association of DPT and attenuated oral polio vaccine (DPT + OPV) in Pakistani children.J Pak Med Assoc. 1989 Feb;39(2):31-5. J Pak Med Assoc. 1989. PMID: 2499700 Clinical Trial.
-
Durability of immunity to diphtheria, tetanus and poliomyelitis after a three dose immunization schedule completed in the first eight months of life.Vaccine. 1989 Aug;7(4):300-2. doi: 10.1016/0264-410x(89)90189-8. Vaccine. 1989. PMID: 2815965
-
Injections and poliomyelitis: what are the risks of vaccine associated paralysis?Dev Biol Stand. 1986;65:123-6. Dev Biol Stand. 1986. PMID: 3549394 Review.
-
[The immunological basis of the administration of DTP-polio vaccine].Verh K Acad Geneeskd Belg. 2000;62(4):245-67. Verh K Acad Geneeskd Belg. 2000. PMID: 11004905 Review. Dutch.
Cited by
-
Expert review on poliovirus immunity and transmission.Risk Anal. 2013 Apr;33(4):544-605. doi: 10.1111/j.1539-6924.2012.01864.x. Epub 2012 Jul 15. Risk Anal. 2013. PMID: 22804479 Free PMC article. Review.
-
Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya.Bull World Health Organ. 1992;70(1):93-103. Bull World Health Organ. 1992. PMID: 1568283 Free PMC article.
-
Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.JAMA Pediatr. 2018 Nov 1;172(11):1045-1052. doi: 10.1001/jamapediatrics.2018.2349. JAMA Pediatr. 2018. PMID: 30208475 Free PMC article. Clinical Trial.
-
Providing monovalent oral polio vaccine type 1 to newborns: findings from a pilot birth-dose project in Moradabad district, India.Bull World Health Organ. 2009 Dec;87(12):955-9. doi: 10.2471/BLT.08.061556. Epub 2009 Oct 1. Bull World Health Organ. 2009. PMID: 20454487 Free PMC article.
-
Recent findings on pertussis epidemiology in Turkey.Eur J Clin Microbiol Infect Dis. 2008 May;27(5):335-41. doi: 10.1007/s10096-007-0442-x. Epub 2008 Jan 9. Eur J Clin Microbiol Infect Dis. 2008. PMID: 18193304
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources